Telehealth and microdosing platform for psychedelic-assisted therapy
AssigneePsilothera, Inc.
InventorsCharles John Atanasio, JR., John Patrick Atanasio, SR.
Life of this patent
Estimating the term…
Loading patent…
AssigneePsilothera, Inc.
InventorsCharles John Atanasio, JR., John Patrick Atanasio, SR.
Estimating the term…
One embodiment provides a method comprising providing to a patient user a questionnaire comprising questions inquiring about well-being of the patient user, receiving responses of the patient user to the questionnaire, and generating a patient user profile by applying machine learning to the responses. The patient user profile comprises diagnostic questions customized for the patient user. The method further comprises providing the patient user profile to a third party user, and initiating a video teleconference between the patient user and the third party user during which the third party user asks the patient user the diagnostic questions to assess and diagnose a mental health of the patient user. The method further comprises providing the patient user with a therapeutic treatment plan prescribed by the third party user based on the assessment and diagnosis. The plan indicates at least one dosing session involving psychedelics for the patient user to complete.
A method comprising:
A system, comprising:
A non-transitory processor-readable medium that includes a program that when executed by a processor performs a method comprising:
Dependencies are inferred from the claim text.